Ultra-Miniature Electrochemical Cell And Fabrication Method
    1.
    发明申请
    Ultra-Miniature Electrochemical Cell And Fabrication Method 审中-公开
    超微型电化学电池和制造方法

    公开(公告)号:US20080085449A1

    公开(公告)日:2008-04-10

    申请号:US11539771

    申请日:2006-10-09

    IPC分类号: H01M2/14 H01M6/00

    摘要: An ultra-miniature electrochemical cell and related fabrication method. The cell includes a cell case having a first cell electrode attached to an inside wall thereof. An electrode-header assembly is also disposed in the cell case. The electrode-header assembly includes an electrode plug providing a second cell electrode, a header assembly attached to the cell case, and a current collector embedded in the electrode plug and extending through the header assembly. The cell further includes an electrolyte-carrying separator disposed in cell case between the first and second electrodes. Advantageously, the second cell electrode may be fabricated using a punching process and joined to the current collector while constrained within tooling in order to minimize the risk of damage to the electrode during handling. This method facilitates the efficient, repeatable fabrication of small uniform electrodes and subsequent attachment of the electrodes to their associated current collectors. The method thus enables the production of electrodes having single millimeter thicknesses or less. Moreover, the method is compatible with many primary cell electrode materials, thereby allowing the production of primary power sources having a form factor and dimensions suitable for percutaneous injection.

    摘要翻译: 超微型电化学电池及相关制造方法。 电池包括具有附接到其内壁的第一电池电极的电池壳体。 电极头组件也设置在电池壳体中。 电极头组件包括提供第二电池电极的电极插头,附接到电池壳体的插头组件和嵌入电极插头中并延伸穿过插头组件的集电器。 电池还包括设置在第一和第二电极之间的电池壳体中的电解质携带隔离体。 有利地,可以使用冲压工艺制造第二电池电极,并且在加工期间被限制在集电器上,以便在处理期间最小化损坏电极的风险。 这种方法有利于小均匀电极的有效,可重复的制造以及随后将电极附着到其相关联的集电器。 因此,该方法能够生产具有单毫米厚度或更小的电极。 此外,该方法与许多初级电池电极材料兼容,从而允许生产具有适于经皮注射的形状因数和尺寸的主电源。

    Carbon Monofluoride Cathode Materials Providing Simplified Elective Replacement Indication
    2.
    发明申请
    Carbon Monofluoride Cathode Materials Providing Simplified Elective Replacement Indication 审中-公开
    提供简单的选择性替代指示的单氟化碳阴极材料

    公开(公告)号:US20070281213A1

    公开(公告)日:2007-12-06

    申请号:US11421973

    申请日:2006-06-02

    申请人: Michael Pyszczek

    发明人: Michael Pyszczek

    IPC分类号: H01M4/58 H01M4/62

    摘要: An electrochemical cell includes an anode, a cathode and an electrolyte operatively associated with the anode and the cathode. The cathode comprises a blend of a first electrochemically active fluorinated carbon material and one or more additional electrochemically active fluorinated carbon materials. The fluorinated carbon materials provide an electrochemical cell voltage characteristic that may be used to predict remaining energy capacity as the electrochemical cell discharges during service. Advantageously, the cathode does not require other electrochemically active materials to achieve the desired voltage characteristic, thereby preserving the favorable energy density properties of fluorinated carbon.

    摘要翻译: 电化学电池包括阳极,阴极和与阳极和阴极可操作地相关联的电解质。 阴极包括第一电化学活性氟化碳材料和一种或多种另外的电化学活性氟化碳材料的共混物。 氟化碳材料提供电化学电池电压特性,其可用于在维修期间电化学电池放电时预测剩余能量容量。 有利地,阴极不需要其它电化学活性材料来实现所需的电压特性,从而保持氟化碳的有利的能量密度特性。

    High power thermoelectric controller
    3.
    发明授权
    High power thermoelectric controller 失效
    大功率热电控制器

    公开(公告)号:US07290395B2

    公开(公告)日:2007-11-06

    申请号:US11244667

    申请日:2005-10-06

    申请人: Jeffrey Deal

    发明人: Jeffrey Deal

    IPC分类号: F25B21/02 F25B29/00

    CPC分类号: F25B21/02 F25B2321/0212

    摘要: A high power thermoelectric controller system is disclosed, capable of operating multiple thermoelectric cooler (TEC) devices, each with a maximum power demand greater than 200 watts. The controller system utilizes interleaved triggering of multiple pulse width modulated power conversion circuits in order to minimize switching transient currents. In another aspect, the system incorporates a novel combination of a PWM controller circuit and H-bridge switching network into a single circuit that reduces the number of components needed to provide closed-loop proportional control of multiple TEC devices in a temperature control system.

    摘要翻译: 公开了一种能够操作多个热电冷却器(TEC)装置的高功率热电控制器系统,每个热电冷却器(TEC)的最大功率需求大于200瓦特。 控制器系统利用多个脉冲宽度调制功率转换电路的交错触发,以便最小化开关瞬态电流。 另一方面,该系统将PWM控制器电路和H桥交换网络的新颖组合结合到单个电路中,从而减少了在温度控制系统中提供多个TEC设备的闭环比例控制所需的组件数量。

    Hybrid battery power source for implantable medical use
    4.
    发明授权
    Hybrid battery power source for implantable medical use 失效
    用于植入式医疗用途的混合电池电源

    公开(公告)号:US07136701B2

    公开(公告)日:2006-11-14

    申请号:US10727349

    申请日:2003-12-03

    IPC分类号: A61N1/40

    摘要: A hybrid battery power source for implantable medical use provides a generally constant low internal resistance during discharge and avoids voltage delays of the type that develop as a result of run down-induced resistance increase in Li/SVO cells. The hybrid battery power source utilizes two batteries or cells, one being a primary cell of relatively high energy density and the other being a secondary cell of relatively low internal resistance that is rechargeable. The primary and secondary cells are connected in a parallel arrangement via a voltage boost/charge control circuit that is powered by the primary cell and adapted to charge the secondary cell while limiting charge/discharge excursions thereof in a manner that optimizes its output for high energy medical device use. The energy storage capacitors of the medical device in which the hybrid battery power source is situated are driven by the secondary cell. The primary cell is used to as an energy source for recharging the secondary cell.

    摘要翻译: 用于可植入医疗用途的混合电池电源在放电期间提供通常恒定的低内部电阻,并且避免由于Li / SVO电池的下降引起的电阻增加而发展的类型的电压延迟。 混合电池电源使用两个电池或电池,一个是相对较高能量密度的主电池,另一个是可再充电的内阻相对较低的二次电池。 主电池和次电池通过电压升压/充电控制电路以并联装置连接,该电压升压/充电控制电路由主电池供电并且适于对二次电池充电,同时以优化其高能量输出的方式限制充电/放电偏移 医疗器械使用。 混合电池电源所在的医疗装置的储能电容器由二次电池驱动。 主电池用作再次充电二次电池的能量源。

    Hybrid battery power source for implantable medical use

    公开(公告)号:US07020519B2

    公开(公告)日:2006-03-28

    申请号:US10407916

    申请日:2003-04-04

    IPC分类号: A61N1/18

    摘要: A hybrid battery power source for implantable medical use provides a generally constant low internal resistance during discharge and avoids voltage delays of the type that develop as a result of run down-induced resistance increase in Li/SVO cells. The hybrid battery power source utilizes two batteries or cells, one being a primary cell of relatively high energy density and the other being a secondary cell of relatively low internal resistance that is rechargeable. The primary and secondary cells are connected in a parallel arrangement via a voltage boost/charge control circuit that is powered by the primary cell and adapted to charge the secondary cell while limiting charge/discharge excursions thereof in a manner that optimizes its output for high energy medical device use. The energy storage capacitors of the medical device in which the hybrid battery power source is situated are driven by the secondary cell. The primary cell is used to as an energy source for recharging the secondary cell.

    Hybrid battery power source for implantable medical use

    公开(公告)号:US07079893B2

    公开(公告)日:2006-07-18

    申请号:US10765559

    申请日:2004-01-24

    IPC分类号: A61N1/40

    摘要: A hybrid battery power source for implantable medical use provides a generally constant low internal resistance during discharge and avoids voltage delays of the type that develop as a result of run down-induced resistance increase in Li/SVO cells. The hybrid battery power source utilizes two batteries or cells, one being a primary cell of relatively high energy density and the other being a secondary cell of relatively low internal resistance that is rechargeable. The primary and secondary cells are connected in a parallel arrangement via a voltage boost/charge control circuit that is powered by the primary cell and adapted to charge the secondary cell while limiting charge/discharge excursions thereof in a manner that optimizes its output for high energy medical device use. The energy storage capacitors of the medical device in which the hybrid battery power source is situated are driven by the secondary cell. The primary cell is used to as an energy source for recharging the secondary cell.

    Hybrid battery power source for implantable medical use
    7.
    发明授权
    Hybrid battery power source for implantable medical use 失效
    用于植入式医疗用途的混合电池电源

    公开(公告)号:US06909915B2

    公开(公告)日:2005-06-21

    申请号:US10350921

    申请日:2003-01-24

    摘要: A hybrid battery power source for implantable medical use provides relatively stable resistance during discharge and avoids the voltage delays that develop as a result of variable resistance increase in Li/SVO cells. The hybrid battery power source utilizes two batteries or cells, one being a primary battery of relatively high energy density and the other being a rechargeable secondary battery of low relatively stable internal resistance. The primary and secondary batteries are connected in a parallel arrangement, preferably via an intermediate voltage boost circuit having an inductor and a pulse generating control circuit therein. The energy storage capacitors of the medical device in which the hybrid battery power source is situated are driven in whole or substantial part by the secondary battery. The primary battery is used to as an energy source for recharging the secondary battery. By arranging the two batteries in parallel, with one serving as a primary battery and the other as a rechargeable secondary battery, all the benefits of the defibrillatory impulse will be obtained and the deficiencies arising from variable voltage delay found in prior art implantable power sources will not be present.

    摘要翻译: 用于可植入医疗用途的混合电池电源在放电期间提供相对稳定的电阻,并且避免由于Li / SVO电池中可变电阻增加而导致的电压延迟。 混合电池电源使用两个电池或电池,一个是相对较高能量密度的一次电池,另一个是具有低相对稳定内阻的可再充电二次电池。 主电池和二次电池以并联的方式连接,优选地经由其中具有电感器和脉冲发生控制电路的中压升压电路。 混合电池电源所在的医疗装置的储能电容器由二次电池全部或大部分驱动。 主电池用作为二次电池充电的能量源。 通过并联布置两个电池,一个充当一次电池,另一个作为可充电二次电池,将获得除颤脉冲的所有益处,并且在现有技术的可植入电源中发现的可变电压延迟引起的缺陷将会 不存在